scispace - formally typeset
I

Indu B. Maiti

Researcher at University of Kentucky

Publications -  67
Citations -  2607

Indu B. Maiti is an academic researcher from University of Kentucky. The author has contributed to research in topics: Promoter & Gene. The author has an hindex of 25, co-authored 67 publications receiving 2412 citations.

Papers
More filters
Patent

Promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PCLSV) and expression of chimeric genes in plants

TL;DR: In this paper, the isolation, modification and use of wild-type and modified viral FLt promoters of PClSV in the expression of chimeric genes in plant cells is described.
Journal ArticleDOI

Plants that express a potyvirus proteinase gene are resistant to virus infection.

TL;DR: Transgenic tobacco plants that express the genome-linked protein/proteinase-coding region of the potyvirus tobacco vein mottling virus (TVMV) were produced and tested for their reaction to inoculation with TVMV and two other potyviruses, indicating that some, but not all, televisionMV genes can be used to confer protection against poty viruses in plants.
Journal ArticleDOI

Promoter/leader deletion analysis and plant expression vectors with the figwort mosaic virus (FMV) full length transcript (FLt) promoter containing single or double enhancer domains

TL;DR: The boundaries required for maximal expression from the promoter/leader region of the full length transcript of figwort mosaic virus (FLt promoter) coupled to reporter genes were defined by 5′ and 3′ deletion analyses.
Journal ArticleDOI

Structure and promoter/leader deletion analysis of mirabilis mosaic virus (MMV) full-length transcript promoter in transgenic plants.

TL;DR: A full-length transcript (FLt) promoter fragment was isolated from a genomic clone of mirabilis mosaic virus (MMV), a double-stranded DNA plant pararetrovirus belonging to the caulimovirus family and showed much greater activity than the CaMV 35S promoter.
Journal ArticleDOI

Enhanced disease resistance conferred by expression of an antimicrobial magainin analog in transgenic tobacco.

TL;DR: The engineered magainin analog peptide Myp30 was found to inhibit spore germination of the oomycete, Peronospora tabacina in vitro, and the growth of a bacterial pathogen Erwinia carotovora subsp.